Ignite Creation Date:
2024-05-05 @ 9:20 PM
Last Modification Date:
2024-10-26 @ 10:03 AM
Study NCT ID:
NCT00869999
Status:
COMPLETED
Last Update Posted:
2014-10-27
First Post:
2009-03-25
Brief Title:
Everolimus Plus Rituximab for RelapsedRefractory Diffuse Large B Cell Lymphoma
Sponsor:
Organization:
Massachusetts General Hospital